Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2012
10/25/2012US20120270824 Mannose derivatives as antagonists of bacterial adhesion
10/25/2012US20120270822 Stabilized formulation for oral administration of therapeutic agents and related methods
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270806 Designer Cyclic Peptides - HIV gp120 Antagonists and their Applications
10/25/2012US20120270775 Crystalline forms of a potent hcv inhibitor
10/25/2012US20120270774 Macrocyclic compounds, compositions comprising them and methods for preventing or treating hiv infection
10/25/2012US20120270772 Lipopeptide compositions and related methods
10/25/2012US20120270769 Methods of using macrocyclic inhibitors of serine protease enzymes
10/25/2012US20120270736 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
10/25/2012US20120269908 Carrier in oil-in-water emulsion form, particularly for cosmetic or dermatological use
10/25/2012US20120269904 Solution containing hypochlorous acid and methods of using same
10/25/2012US20120269885 Vaccine for Modulating Between T1 and T2 Immune Responses
10/25/2012US20120269884 Vaccine for Modulating Between T1 and T2 Immune Responses
10/25/2012US20120269879 Compositions comprising honey and a super- absorbent material
10/25/2012US20120269874 Compositions for topical application comprising a peroxide and retinoid
10/25/2012US20120269859 Multimer of extracellular domain of cell surface functional molecule
10/25/2012US20120269857 Analogs of alpha galactosylceramide and uses thereof
10/25/2012US20120269855 Toll-like receptor 5 ligands and methods of use
10/25/2012US20120269854 Method of Enhancing KSHV LANA1 Immunogenicity
10/25/2012US20120269853 Attenuated dengue virus vaccine containing adaptive mutation from mrc-5 cells
10/25/2012US20120269852 Adjuvated Influenza Vaccine and Use Thereof
10/25/2012US20120269851 Expression cassettes endcoding hiv-1 south african subtype c modified proteins
10/25/2012US20120269850 Method of Inducing an Immune Response
10/25/2012US20120269849 Attenuated influenza viruses and vaccines
10/25/2012US20120269848 Compositions and methods for treating and preventing infection
10/25/2012US20120269847 Antigen purification process for pertactin antigen
10/25/2012US20120269846 Adjuvanted Rabies Vaccine with Improved Viscosity Profile
10/25/2012US20120269844 Vaccines for the treatment of neoplasias from viral capsids of birnavirus containing antigens of the human papillomavirus
10/25/2012US20120269843 S. epidermidis antigens
10/25/2012US20120269840 Expression of hiv polypeptides and production of virus-like particles
10/25/2012US20120269838 Carrier conjugates of il-23-peptides and their induced antibodies
10/25/2012US20120269834 Immunoglobulin cleavage fragment vaccine compositions
10/25/2012US20120269821 Hiv-1 antibodies
10/25/2012US20120269818 Methods for treating infection by hpv
10/25/2012US20120269813 Polyclonal bispecific antibody compositions and method of use
10/25/2012US20120269799 Diagnostic and treatment methods using a ligand library
10/25/2012US20120269787 Systemic, allogenic stem cell therapies for treatment of diseases in equines
10/25/2012US20120269785 Systemic, allogenic stem cell therapies for treatment of diseases in canines
10/25/2012US20120269783 Composition containing autologous mononuclear cells and pig collagen scaffold in paste form and its use in the preparation of a medicament for surgical treatment
10/25/2012US20120269772 Lipid depot formulations
10/25/2012US20120269771 Sialochimeric compounds
10/25/2012US20120269769 Hepatitis C Inhibitor Compounds
10/25/2012US20120269768 Antiviral product
10/25/2012US20120269766 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
10/25/2012US20120269751 Composition for topical application, uses thereof, applicator device and kit of parts
10/25/2012US20120269741 Liquid Compositions for Oral Cavity
10/24/2012EP2514761A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
10/24/2012EP2514759A1 Triterpene derivative, and prophylactic or therapeutic agent for chronic hepatitis c
10/24/2012EP2514746A1 Stable crystal of 4-oxoquinoline compound
10/24/2012EP2514439A1 Anti-TSG101antibodies and their uses for treatment of viral infections
10/24/2012EP2514436A2 Compositions and methods for treatment of microbial disorders
10/24/2012EP2514410A2 Liposome composition, preparation method thereof, and usage of the composition as pneumonia vaccine
10/24/2012EP2513131A1 Novel 3´-deoxy-3´-methylidene- -l-nucleosides
10/24/2012EP2513128A2 Mannose derivatives as antagonists of bacterial adhesion
10/24/2012EP2513115A1 Tricyclic antibiotics
10/24/2012EP2513113A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
10/24/2012EP2513112A2 Method for late introduction of the (8r)-hydroxyl group in carbapenem beta-lactam antibiotic synthesis
10/24/2012EP2513111A1 Mk2 inhibitors
10/24/2012EP2513092A1 Heterocyclic antiviral compounds
10/24/2012EP2513072A1 Pyrazine derivatives,process for manufacture and use thereof
10/24/2012EP2513064A2 Compounds, compositions and methods for controlling biofilms
10/24/2012EP2513060A1 Alpha-crystalline form of carbabenzpyride
10/24/2012EP2512491A1 Hbv antisense inhibitors
10/24/2012EP2512485A1 New steroid inhibitors of pgp for use for inhibiting multidrug resistance
10/24/2012EP2512477A1 Hcv combination therapy
10/24/2012EP2512463A1 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail
10/24/2012EP2512447A1 Antifungal composition intended to be applied to a perforated nail
10/24/2012EP2512230A1 Non-irritating ophthalmic povidone-iodine compositions
10/24/2012CN102753582A Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
10/24/2012CN102753563A Nucleoside analogs
10/24/2012CN102753562A Mannose derivatives as antagonists of bacterial adhesion
10/24/2012CN102753558A Nitroimidazooxazines and their uses in anti-tubercular therapy
10/24/2012CN102753553A 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8H-purin-8-one maleate
10/24/2012CN102753543A A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative
10/24/2012CN102753542A Substituted benzoazepines as toll-like receptor modulators
10/24/2012CN102753526A Pyridinone hydroxycyclopentyl carboxamides: HIV integrase inhibitors with therapeutic applications
10/24/2012CN102753173A Hcv combination therapy
10/24/2012CN102750459A Anti-HPV (human papillomavirus) medicine virtual screening method by using DNA helicase E1 of HPV as target point
10/24/2012CN102747103A AIDS vaccine of double-deletion replicative vaccinia virus based on A52L gene and B8R gene
10/24/2012CN102747092A Recombinant defective adenoviruses expressing O type foot and mouth disease virus empty capsid, and applications thereof
10/24/2012CN102747048A Mycobacterium tuberculosis candidate antigen and its application
10/24/2012CN102747047A Human papillomaviruse type hybrid virus-like particles and preparation method thereof
10/24/2012CN102747045A Swine influenza virus H1N1 SIVTJ inactivated vaccine and preparation method thereof
10/24/2012CN102747024A EHEC 0157:H7 multivalent fliC-hcpA-tir-eae recombinant strain and vaccine
10/24/2012CN102747003A Screening and application of probiotic Enterococcus faecium
10/24/2012CN102746434A Cream-body povidon-iodine and method of preparing same
10/24/2012CN102746416A Preparation method and application of fieldbalm polysaccharide
10/24/2012CN102746398A Single-chain antibody ZL1 against chicken-derived Newcastle disease virus P protein, preparation method and application thereof
10/24/2012CN102746397A Single-chain antibody ZL2 against chicken-derived Newcastle disease virus P protein, preparation method and application thereof
10/24/2012CN102746389A Streptococcus adhesion antigen GAPDH and preparation method thereof
10/24/2012CN102746388A Streptococcus protective antigen C5a and preparation method thereof
10/24/2012CN102746387A DNA (Deoxyribose Nucleic Acid) vaccine of HCV (Hepatitis C Virus) and preparation method thereof
10/24/2012CN102746384A High purity caspofungin or its salt and its preparation method and application
10/24/2012CN102746381A Helicobacter pylori antigen HLA restrictive immunodominance epitope peptide and preparation method and application thereof
10/24/2012CN102746377A Epitope peptide of mycobacterium trberculosis protein antigen, and its application
10/24/2012CN102746376A Cyclopeptide antibiotics and preparation method thereof and application of cylopeptide antibiotics in preparation of antibacterial agents
10/24/2012CN102746353A Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
10/24/2012CN102746344A Cinnamic acid derivative crystal and preparation method thereof
10/24/2012CN102746341A Thiosemicarbazide Schiff alkali bismuth complex and preparation method thereof
10/24/2012CN102746340A Aminobenzothiazole Schiff alkali bismuth complex and preparation method thereof
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 1798